GLP-1 drugs could reduce American mortality by 6.4%, a new study reveals

A new study has discovered that diabetes and weight loss drugs could considerably reduce mortality for Americans.

Researchers from Swiss Re, a reinsurance company in Zurich, Switzerland, have published estimates that GLP-1 medicines could lead to a reduction of 6.4% of the mortality in the United States by 2045.

In the United Kingdom, more than a 5% reduction in mortality was projected over the same 20 years.

Could GLP-1 weight loss drugs like Ozempic become the “all medication”?

The United States and the United Kingdom share high obesity rates and “high absorption” in GLP-1 medications, researchers noted in a press release.

America has the highest rate of obesity in the world, because more than 40% of the adult population is obese. About 30% of British adults are obese.

GLP-1 drugs could lead to a 6.4% reduction in mortality from all causes in the United States by 2045, the researchers’ project. (istock)

Obesity is a factor that has “blocked the progress of life expectancy” because it is linked to 70% of the main causes of death in high -income countries, according to researchers. These causes include heart disease, brain vascular accidents, Alzheimer’s disease and many cancers.

“By improving reference risk factors, GLP-1 drugs can contribute to improving mortality over time, saving millions of premature deaths,” commented the researchers.

Why microdosing ozempic could become as common as taking a multivitamin

To maximize the advantages of GLP-1 drugs, individuals must also implement changes in lifestyle that support “long-term health improvements”, advised experts.

Without lasting changes, such as diet and exercise, withdrawal of weight and rebound effects are common, according to studies.

Obesity is linked to 70% of the main causes of death in high income countries. (istock)

Paul Murray, CEO of Life & Health Reassurance, commented on these results in a press release, noting that GLP-1 drugs hold “a significant promise to help us beat the obesity epidemic”.

Click here to obtain the Fox News app

“Our research emphasizes that all the benefit will come to go beyond medication,” he wrote. “As an assessor, we are able to create partnerships, support politics and encourage people to make significant lifestyle changes by emphasizing prevention.”

Murray added: “If we get things correctly, we can strengthen the insurance net of insurance and contribute to people living longer and healthier.”

Click here to register for our Health Newsletter

Recent research has revealed that GLP-1 drugs can improve a variety of conditions beyond weight loss and diabetes.

These include cardiac, renal, hepatic and skin conditions, as well as arthritis, cognitive decline, dependence and even certain cancers.

To maximize the advantages of GLP-1 drugs, individuals should also implement changes in lifestyle that support “long-term health improvements”, advised experts. (istock)

Triple certified weight loss doctor, Dr. Sue Decotiis, who is based in New York, confirmed in an interview with Fox News Digital How Patients experienced in various conditions during these drugs.

The fat cells, which are burned by an increase in insulin from GLP-1 drugs, produce cytokines responsible for inflammation in the body, potentially leading to autoimmune diseases, cancer and other problems, according to the expert.

For more health items, visit www.foxnews.com/health

“By reducing the volume of fat cells in the body, we reduce all these inflammatory cytokines,” she said. “And that’s why we see a lot of effects that we see.”

“It is important to do it in the right way and really treat these drugs with respect, treat your body with respect and understand that this is a wonderful tool if it is used in the right way.”